Cell Viability Assays Market - Global Industry Analysis
Cell Viability Assays Market by Product (Consumables and Instruments), by Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Others), and by End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025
Global cell viability assays market expected to generate around USD 5.12 billion by 2025, at a CAGR of around 8.3% between 2019 and 2025. The growing occurrence of chronic diseases is fueling the research activities to treat these diseases, which is driving the global cell viability assays market.
Description
The report covers a forecast and an analysis of the cell viability assays market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the cell viability assays market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cell viability assays market on a global level.
In order to give the users of this report a comprehensive view of the cell viability assays market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new assay kits launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.
The study provides a decisive view of the cell viability assays market on the basis of product, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Some key players of the global cell viability assays market are Bio-Rad Laboratories, Inc., GE Healthcare, PerkinElmer, Danaher Corporation, Promega Corporation, Thermo Fischer Scientific, BioTek Instruments, Biotium, Merck, Becton, Dickinson, and Company, and G-Biosciences, among others.
This report segments the global cell viability assays market as follows:
Global Cell Viability Assays Market: Product Analysis
- Consumables
- Assay Kits
- Tetrazolium Reduction Assay Kits
- Resazurin Cell Viability Assay Kits
- Calcein-AM Cell Viability Assay Kits
- Others
- Reagents
- Microplates
- Assay Kits
- Instruments
- Automated Cell Counters
- Spectrophotometers
- Cell Imaging and Analysis Systems
- Flow Cytometers
Global Cell Viability Assays Market: Application Analysis
- Basic Research
- Stem Cell Research
- Drug Discovery and Development
- Clinical and Diagnostic Applications
- Others
Global Cell Viability Assays Market: End-User Analysis
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Laboratories
- Others
Global Cell Viability Assays Market: Regional Analysis
- North America
- U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global cell viability assays market, 2016-2025 (USD Billion)
- 2.2. Global cell viability assays market: Snapshot
- Chapter 3. Cell Viability Assays Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global cell viability assays market drivers: Impact analysis
- 3.2.2. Rising Incidence and Prevalence of Chronic and Infectious Diseases
- 3.2.3. Growing Availability of Funds for Research
- 3.2.4. Rising Demand for Cell-Based Assays in Research
- 3.2.5. Increasing Focus on the Development of Cell-Based Therapeutics
- 3.3. Market Restraints
- 3.3.1. Global cell viability assays market restraints: Impact analysis
- 3.3.2. High Cost of Instruments
- 3.4. Opportunities
- 3.4.1. Emerging Markets
- 3.4.2. Growing Focus on Stem Cell Research
- 3.5. Porter's Five Forces analysis
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by product
- 3.6.2. Market attractiveness analysis, by application
- 3.6.3. Market attractiveness analysis, by end-user
- 3.6.4. Market attractiveness analysis, by region
- Chapter 4. Global Cell Viability Assays Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global cell viability assays market: company market share, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New instruments launch
- 4.2.3. Agreements, partnerships, collaborations, and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global Cell Viability Assays Market - Product Analysis
- 5.1. Global cell viability assays market: Product overview
- 5.1.1. Global cell viability assays market revenue share, by product, 2018 and 2025
- 5.2. Consumables
- 5.2.1. Global cell viability assays market for consumables, 2016-2025 (USD Billion)
- 5.3. Instruments
- 5.3.1. Global cell viability assays market for instruments, 2016-2025 (USD Billion)
- 5.1. Global cell viability assays market: Product overview
- Chapter 6. Global Cell Viability Assays Market - Application Analysis
- 6.1. Global cell viability assays market: Application overview
- 6.1.1. Global cell viability assays market revenue share, by application, 2018 and 2025
- 6.2. Basic Research
- 6.2.1. Global cell viability assays market for basic research, 2016-2025 (USD Billion)
- 6.3. Stem Cell Research
- 6.3.1. Global cell viability assays market for stem cell research, 2016-2025 (USD Billion)
- 6.4. Drug Discovery & Development
- 6.4.1. Global cell viability assays market for drug discovery & development, 2016-2025 (USD Billion)
- 6.5. Clinical & Diagnostic Applications
- 6.5.1. Global cell viability assays market for clinical and diagnostic applications, 2016-2025 (USD Billion)
- 6.6. Others
- 6.6.1. Global cell viability assays market for others, 2016-2025 (USD Billion)
- 6.1. Global cell viability assays market: Application overview
- Chapter 7. Global Cell Viability Assays Market - End-User Analysis
- 7.1. Global cell viability assays market: End-User overview
- 7.1.1. Global cell viability assays market revenue share, by End-User, 2018 and 2025
- 7.2. Academic and Research Institutes
- 7.2.1. Global cell viability assays market for academic and research institutes, 2016-2025 (USD Billion)
- 7.3. Pharmaceutical and Biotechnology Companies
- 7.3.1. Global cell viability assays market for pharmaceutical and biotechnology companies, 2016-2025 (USD Billion)
- 7.4. Hospitals and Diagnostic Laboratories
- 7.4.1. Global cell viability assays market for hospitals and diagnostic laboratories, 2016-2025 (USD Billion)
- 7.5. Others
- 7.5.1. Global cell viability assays market for others, 2016-2025 (USD Billion)
- 7.1. Global cell viability assays market: End-User overview
- Chapter 8. Global Cell Viability Assays Market - Regional Analysis
- 8.1. Global cell viability assays market: Regional overview
- 8.1.1. Global cell viability assays market revenue share, by region, 2018 and 2025
- 8.2. North America
- 8.2.1. North America cell viability assays market, 2016-2025 (USD Billion)
- 8.2.2. North America cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.2.3. North America cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.2.4. North America cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.2.5. The U.S.
- 8.2.5.1. The U.S. cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.2.5.2. The U.S. cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.2.5.3. The U.S. cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.2.6. Canada
- 8.2.6.1. Canada cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.2.6.2. Canada cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.2.6.3. Canada cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.3. Europe
- 8.3.1. Europe cell viability assays market, 2016-2025 (USD Billion)
- 8.3.2. Europe cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.3.2.1. Europe cell viability assays market revenue, by consumables, 2016-2025 (USD Billion)
- 8.3.3. Europe cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.3.4. Europe cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.3.5. UK
- 8.3.5.1. UK cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.3.5.2. UK cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.3.5.3. UK cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.3.6. Germany
- 8.3.6.1. Germany cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.3.6.2. Germany cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.3.6.3. Germany cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.3.7. France
- 8.3.7.1. France cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.3.7.2. France cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.3.7.3. France cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.3.8. Rest of Europe
- 8.3.8.1. Rest of Europe cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.3.8.2. Rest of Europe cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.3.8.3. Rest of Europe cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific cell viability assays market, 2016-2025 (USD Billion)
- 8.4.2. Asia Pacific cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.4.3. Asia Pacific cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.4.4. Asia Pacific cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.4.5. China
- 8.4.5.1. China cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.4.5.2. China cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.4.5.3. China cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.4.6. Japan
- 8.4.6.1. Japan cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.4.6.2. Japan cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.4.6.3. Japan cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.4.7. India
- 8.4.7.1. India cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.4.7.2. India cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.4.7.3. India cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.4.8.2. Rest of Asia Pacific cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.4.8.3. Rest of Asia Pacific cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.5. Latin America
- 8.5.1. Latin America cell viability assays market, 2016-2025 (USD Billion)
- 8.5.2. Latin America cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.5.3. Latin America cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.5.4. Latin America cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.5.5. Brazil
- 8.5.5.1. Brazil cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.5.5.2. Brazil cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.5.5.3. Brazil cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.5.6. Rest of Latin America
- 8.5.6.1. Rest of Latin America cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.5.6.2. Rest of Latin America cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.5.6.3. Rest of Latin America cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa cell viability assays market, 2016-2025 (USD Billion)
- 8.6.2. The Middle East and Africa cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.6.3. The Middle East and Africa cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.6.4. The Middle East and Africa cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.1. Global cell viability assays market: Regional overview
- Chapter 9. Company Profile
- 9.1. GE Healthcare
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategy
- 9.1.5. Recent Developments
- 9.2. Bio-Rad Laboratories, Inc.
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategy
- 9.2.5. Recent Developments
- 9.3. PerkinElmer
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategy
- 9.3.5. Recent Developments
- 9.4. Danaher Corporation
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategy
- 9.4.5. Recent Developments
- 9.5. Promega Corporation
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategy
- 9.5.5. Recent Developments
- 9.6. Thermo Fischer Scientific
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategy
- 9.6.5. Recent Developments
- 9.7. BioTek Instruments
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategy
- 9.7.5. Recent Developments
- 9.8. Biotium
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategy
- 9.8.5. Recent Developments
- 9.9. Becton, Dickinson, and Company
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategy
- 9.9.5. Recent Developments
- 9.10. G-Biosciences
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategy
- 9.10.5. Recent Developments
- 9.11. Merck
- 9.11.1. Overview
- 9.11.2. Financials
- 9.11.3. Product Portfolio
- 9.11.4. Business Strategy
- 9.11.5. Recent Developments
- 9.1. GE Healthcare
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global cell viability assays market revenue, 2016–2025 (USD Billion)
4. Porter’s Five Forces analysis
5. Cell Viability Assays market attractiveness analysis, by product
6. Cell Viability Assays market attractiveness analysis, by application
7. Cell Viability Assays market attractiveness analysis, by End-User
8. Cell Viability Assays market: market attractiveness analysis, by region
9. Company market share analysis, 2018
10. Global cell viability assays market revenue share by product, 2018 and 2025
11. Global cell viability assays market for consumables, 2016–2025 (USD Billion)
12. Global cell viability assays market for instruments, 2016–2025 (USD Billion)
13. Global cell viability assays market revenue share by application, 2018 and 2025
14. Global cell viability assays market for basic research, 2016–2025 (USD Billion)
15. Global cell viability assays market for stem cell research, 2016–2025 (USD Billion)
16. Global cell viability assays market for drug discovery & development, 2016–2025 (USD Billion)
17. Global cell viability assays market for clinical & diagnostic applications, 2016–2025 (USD Billion)
18. Global cell viability assays market for others, 2016–2025 (USD Billion)
19. Global cell viability assays market revenue share by End-User, 2018 and 2025
20. Global cell viability assays market for academic and research institutes, 2016–2025 (USD Billion)
21. Global cell viability assays market for pharmaceutical and biotechnology companies, 2016–2025 (USD Billion)
22. Global cell viability assays market for hospitals and diagnostic laboratories, 2016–2025 (USD Billion)
23. Global cell viability assays market for others, 2016–2025 (USD Billion)
24. North America cell viability assays market, 2016–2025 (USD Billion)
25. Europe cell viability assays market, 2016–2025 (USD Billion)
26. Asia Pacific cell viability assays market, 2016–2025 (USD Billion)
27. Latin America cell viability assays market, 2016–2025 (USD Billion)
28. The Middle East and Africa cell viability assays market, 2016–2025 (USD Billion)
Table Of Tables
List of Tables
1. Global cell viability assays market: Market Snapshot 2. Drivers of global cell viability assays market: Impact analysis
3. Restraints of global cell viability assays market: Impact analysis
4. North America cell viability assays market revenue, by product, 2016–2025 (USD Billion)
5. North America cell viability assays market revenue, by application, 2016–2025 (USD Billion)
6. North America cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
7. The U.S. cell viability assays market revenue, by product, 2016–2025 (USD Billion)
8. The U.S. cell viability assays market revenue, by application, 2016–2025 (USD Billion)
9. The U.S. cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
10. Canada cell viability assays market revenue, by product, 2016–2025 (USD Billion)
11. Canada cell viability assays market revenue, by application, 2016–2025 (USD Billion)
12. Canada cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
13. Europe cell viability assays market revenue, by product, 2016–2025 (USD Billion)
14. Europe cell viability assays market revenue, by application, 2016–2025 (USD Billion)
15. Europe cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
16. UK cell viability assays market revenue, by product, 2016–2025 (USD Billion)
17. UK cell viability assays market revenue, by application, 2016–2025 (USD Billion)
18. UK cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
19. Germany cell viability assays market revenue, by product, 2016–2025 (USD Billion)
20. Germany cell viability assays market revenue, by application, 2016–2025 (USD Billion)
21. Germany cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
22. France cell viability assays market revenue, by product, 2016–2025 (USD Billion)
23. France cell viability assays market revenue, by application, 2016–2025 (USD Billion)
24. France cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
25. Rest of Europe cell viability assays market revenue, by product, 2016–2025 (USD Billion)
26. Rest of Europe cell viability assays market revenue, by application, 2016–2025 (USD Billion)
27. Rest of Europe cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
28. Asia Pacific cell viability assays market revenue, by product, 2016–2025 (USD Billion)
29. Asia Pacific cell viability assays market revenue, by application, 2016–2025 (USD Billion)
30. Asia Pacific cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
31. China cell viability assays market revenue, by product, 2016–2025 (USD Billion)
32. China cell viability assays market revenue, by application, 2016–2025 (USD Billion)
33. China cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
34. Japan cell viability assays market revenue, by product, 2016–2025 (USD Billion)
35. Japan cell viability assays market revenue, by application, 2016–2025 (USD Billion)
36. Japan cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
37. India cell viability assays market revenue, by product, 2016–2025 (USD Billion)
38. India cell viability assays market revenue, by application, 2016–2025 (USD Billion)
39. India cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
40. Rest of Asia Pacific cell viability assays market revenue, by product, 2016–2025 (USD Billion)
41. Rest of Asia Pacific cell viability assays market revenue, by application, 2016–2025 (USD Billion)
42. Rest of Asia Pacific cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
43. Latin America cell viability assays market revenue, by product, 2016–2025 (USD Billion)
44. Latin America cell viability assays market revenue, by application, 2016–2025 (USD Billion)
45. Latin America cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
46. Brazil cell viability assays market revenue, by product, 2016–2025 (USD Billion)
47. Brazil cell viability assays market revenue, by application, 2016–2025 (USD Billion)
48. Brazil cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
49. Rest of Latin America cell viability assays market revenue, by product, 2016–2025 (USD Billion)
50. Rest of Latin America cell viability assays market revenue, by application, 2016–2025 (USD Billion)
51. Rest of Latin America cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
52. The Middle East and Africa cell viability assays market revenue, by product, 2016–2025 (USD Billion)
53. The Middle East and Africa cell viability assays market revenue, by application, 2016–2025 (USD Billion)
54. The Middle East and Africa cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
Methodology
Free Analysis
Cell viability assay is an assay technique where the effect of a compound on cell activity is checked. This is generally used during drug development procedures to check whether the developed drug is useful for the treatment of diseases. In this, the ongoing cellular activities or the enzyme activities of a cell can also be confirmed.
According to the Statista, in 2016, about 17.8 million deaths occurred due to cardiovascular diseases. The growing occurrence of chronic diseases is fueling the research activities to treat these diseases, which is driving the global cell viability assays market. To confirm the effect of various developed compounds on cells, the demand for cell viability assays is rising. Therefore, the growing prevalence of chronic and infectious diseases is fueling the growth of the global cell viability assays market. The growing investments made by the government for drug development, increasing the cell-based research activities, development of technologically advanced products for cell-based assays, and the development of cell-based therapeutics are also boosting the growth of the global cell viability assays market. However, the high cost of the cell viability assay instruments may hinder the cell viability assays market in the future.
The global cell viability assays market is divided into product, application, and end-user. By product, the cell viability assays market is segmented into instruments and consumables. The consumables segment is further divided into assay kits, reagents, and microplates. Assay kits include resazurin cell viability assay kits, tetrazolium reduction assay kits, calcein-AM cell viability assay kits, and others. The instruments segment includes cell imaging and analysis systems, automated cell counters, spectrophotometers, and flow cytometers. The consumables segment is anticipated to dominate the cell viability assays market globally in the future, due to the growing demand for assay kits and reagents in research activities. By application, the market is divided into stem cell research, clinical and diagnostic applications, basic research, drug discovery and development, and others. The growing research activities taking place in drug and biosimilar product development sector are fueling the drug discovery and development segment. By end-user, the market is segmented into hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, academic and research institutes, and others. Pharmaceutical and biotechnological companies dominated the market in 2018.
By region, North America is predicted to lead the global cell viability assays market in the upcoming years, owing to an increase in the prevalence of infectious diseases, growing research activities, and developed research and clinical laboratories. The Asia Pacific cell viability assays market is expected to show the highest growth in the future, owing to the presence of a large patient pool, the high prevalence of chronic and infectious diseases, and huge government investments for research activities.
Some key players of the global cell viability assays market are Bio-Rad Laboratories, Inc., GE Healthcare, PerkinElmer, Danaher Corporation, Promega Corporation, Thermo Fischer Scientific, BioTek Instruments, Biotium, Merck, Becton, Dickinson, and Company, and G-Biosciences, among others.
Choose License Type
RelatedNews
Office Address
Contact Us
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
Asia Pacific Office
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
Contact #
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We Are On Social
Industry Press Release
We Accept
We have secured system to process your transaction.
How it Works?
Our Company
Business Hours
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed